Sun ZJ - Search Results

1

Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead.

Li SJ, Sun ZJ. Li SJ, et al. Among authors: sun zj. Cancer Lett. 2022 Dec 1;550:215937. doi: 10.1016/j.canlet.2022.215937. Epub 2022 Oct 4. Cancer Lett. 2022. PMID: 36206966 Review.

2

CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.

Li H, Liu YT, Chen L, Zhou JJ, Chen DR, Li SJ, Sun ZJ. Li H, et al. Among authors: sun zj. Mol Carcinog. 2021 Aug;60(8):556-566. doi: 10.1002/mc.23323. Epub 2021 Jun 1. Mol Carcinog. 2021. PMID: 34061408

3

Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges.

Li SJ, Chen JX, Sun ZJ. Li SJ, et al. Among authors: sun zj. Cancer Commun (Lond). 2021 Sep;41(9):830-850. doi: 10.1002/cac2.12183. Epub 2021 Jun 17. Cancer Commun (Lond). 2021. PMID: 34137513 Free PMC article. Review.

4

Gas and gas-generating nanoplatforms in cancer therapy.

Jing YZ, Li SJ, Sun ZJ. Jing YZ, et al. Among authors: sun zj. J Mater Chem B. 2021 Oct 27;9(41):8541-8557. doi: 10.1039/d1tb01661j. J Mater Chem B. 2021. PMID: 34608920 Review.

5

Bioengineered nanogels for cancer immunotherapy.

Ma X, Li SJ, Liu Y, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Ma X, et al. Among authors: sun zj. Chem Soc Rev. 2022 Jun 20;51(12):5136-5174. doi: 10.1039/d2cs00247g. Chem Soc Rev. 2022. PMID: 35666131 Review.

6

The immune checkpoint inhibitors treatment of head and neck squamous cell carcinoma: an expert consensus.

Liu L, Xiang Z, Li Y, Guo W, Yang K, Wang J, Sun Z, Ren G, Zhang J, Sun M, Ran W, Huang G, Tang Z, Li L. Liu L, et al. Hua Xi Kou Qiang Yi Xue Za Zhi. 2022 Dec 1;40(6):619-628. doi: 10.7518/hxkq.2022.06.001. Hua Xi Kou Qiang Yi Xue Za Zhi. 2022. PMID: 36416313 Free PMC article. Chinese, English.

7

A Dual-Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis.

Su W, Qiu W, Li SJ, Wang S, Xie J, Yang QC, Xu J, Zhang J, Xu Z, Sun ZJ. Su W, et al. Among authors: sun zj. Adv Mater. 2023 Mar;35(11):e2209379. doi: 10.1002/adma.202209379. Epub 2023 Feb 3. Adv Mater. 2023. PMID: 36545949

8

Cancer stem cell-immune cell collusion in immunotherapy.

Wang YY, Wang WD, Sun ZJ. Wang YY, et al. Among authors: sun zj. Int J Cancer. 2023 Aug 15;153(4):694-708. doi: 10.1002/ijc.34421. Epub 2023 Jan 11. Int J Cancer. 2023. PMID: 36602290 Review.

9

Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma.

Zhang B, Li H, Liu YT, Xiong D, Zhang L, Sun ZJ. Zhang B, et al. Among authors: sun zj. Cancer Lett. 2023 Apr 1;558:216105. doi: 10.1016/j.canlet.2023.216105. Epub 2023 Feb 24. Cancer Lett. 2023. PMID: 36841416

10

Tumor-host colluding through erythroid progenitor cells: Mechanisms and opportunities.

Wang YY, Wu ZZ, Huang CF, Sun ZJ. Wang YY, et al. Among authors: sun zj. Cancer Lett. 2023 Jun 1;563:216193. doi: 10.1016/j.canlet.2023.216193. Epub 2023 Apr 23. Cancer Lett. 2023. PMID: 37088326 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page